Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: The Multidisciplinary Approach to de Novo Metastatic Inflammatory Breast Cancer: A Combined Systemic and Locoregional Strategy

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Soran A, Ozmen V, Ozbas S, et al. Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01. Ann Surg Oncol. 2018;25:3141–9.

    Article  Google Scholar 

  2. Badwe R, Gupta S, Nair N, Parmar V, Hawaldar R. Survival of patients with metastatic breast cancer with or without locoregional therapy: authors’ reply. Lancet Oncol. 2015;16:e587–8.

    Article  Google Scholar 

  3. Khan SA, Zhao F, Solin LJ, Goldstein LJ, Cella D, Basik M, et al. A randomized phase III trial of systemic therapy plus early local therapy versus systemic therapy alone in women with de novo stage IV breast cancer: a trial of the ECOG-ACRIN Research Group (E2108). J Clin Oncol. 2020. https://doi.org/10.1200/jco.2020.38.18_suppl.lba2.

    Article  PubMed  Google Scholar 

  4. Weiss A, Menen RS, Lin HY, et al. Factors associated with improved outcomes for metastatic inflammatory breast cancer patients. Breast Cancer Res Treat. 2018;169:615–23.

    Article  Google Scholar 

  5. Akay CL, Ueno NT, Chisholm GB, et al. Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancer. Cancer. 2014;120:1319–28.

    Article  Google Scholar 

  6. Partain N, Postlewait LM, Teshome M, Rosso K, Hall C, Song J, et al. The role of mastectomy in de novo stage IV inflammatory breast cancer. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-09392-8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Breast Surgical Oncology, Division of Surgery, University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Unit 1434, Houston, TX, USA

    Lauren M. Postlewait MD & Anthony Lucci MD, FACS

  2. Division of Surgical Oncology, Department of Surgery, Emory University, Atlanta, GA, USA

    Lauren M. Postlewait MD

  3. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Anthony Lucci MD, FACS

Authors
  1. Lauren M. Postlewait MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony Lucci MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anthony Lucci MD, FACS.

Ethics declarations

Disclosure

The authors declare that they have no conflict of interst.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Postlewait, L.M., Lucci, A. ASO Author Reflections: The Multidisciplinary Approach to de Novo Metastatic Inflammatory Breast Cancer: A Combined Systemic and Locoregional Strategy. Ann Surg Oncol 28, 4275–4276 (2021). https://doi.org/10.1245/s10434-020-09421-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09421-6

Search

Navigation